By Lorna Patrick, Chief Operating Officer, Upperton In the world of outsourced drug development and manufacturing, risk ...

FDA reversal, patent relief, and mRESVIA risks show a commoditized market and lofty $20B valuation. See more here.

Brains Bioceutical Corp. (“Brains Bio”), a global life sciences company advancing a clinically validated portfolio of therapeutic and pharmaceutical programs, today announced the appointment of Dr.

The Trump administration is now considering Houman Hemmati to lead the FDA’s Center for Biologics Evaluation and Research, ...

Further advancements in Europe and the US increase capacity and process efficiencyConstruction of new clinical manufacturing ...

Photo by Carolyn Lagattuta The research aims to uncover the molecular and cellular mechanisms underlying autism and ...

Ahead of The Festival of Genomics, Biodata & AI in Boston, we’re sitting down with some of our expert speakers […] ...

Amidst rising layoffs in key biotech hubs, global demand for specialized life sciences talent is driving a more borderless, ...

Those who remember the 1990s may also feel like history's repeating itself. Mark Hartley investigates how the FTSE 100 today compares to back then. The post The FTSE 100 looks a lot like the late ’90s ...

The scientists driving Neion Bio’s effort to engineer chickens as scalable, lower-cost platforms for biologics manufacturing.

The last time I spoke about Revolution Medicines (RVMD) it was with a Seeking Alpha article entitled "Revolution Medicines: ...

Three seasoned attorneys from the national intellectual property firm Banner Witcoff have launched KellDann Law PLLC, a ...